EBMT
@TheEBMT
Followers
13K
Following
7K
Media
2K
Statuses
8K
We are a non-profit medical and scientific organisation working to save and improve the lives of patients with blood-related disorders. š Join us at #EBMT26
Joined July 2013
Want to hear the interim results from the Phase II trial evaluating rapcabtagene autoleucel in first-line high-risk large B-cell #lymphoma? Keep an eye out for the interview we just filmed with Pere Barba (@Hemato_Vhebron) at #CART26 - coming soon to https://t.co/O9p0vDBrzw!
0
2
3
#CART26 Madame President @AnnaSureda5 @TheEBMT @ICO_oncologia chair in the first session of the day! #CLL & #Lymphoma
@TheEBMT_Trainee @EHA_Hematology @young_eha
0
3
9
0
2
14
@c_thieblemont excellent review on #Lymphoma treatment strategies #CART26 Great results with new available approaches! @TheEBMT_Trainee @TheEBMT @EHA_Hematology @young_eha
0
3
5
LIVE NOW #CART26 Great discussion panel for wrapping up 2nd day at #MallorCART! @TheEBMT @TheEBMT_Trainee @EHA_Hematology @young_eha
@AnnalisaRugger1 @carlhjune @MariaThemeli1 @MarcelaMaus @lab_rezvani @michelsedelain
0
2
4
A brilliant day 2 in Palma at the @TheEBMT_Nurses sessions.. insightful topics and privileged to have the opportunity to present and share my experiences of CAR-T delivery š #CART26 @TheEBMT
0
3
11
Are you ready for day 3 #CART26? Letās begin! @EHA_Hematology @young_eha @TheEBMT_Trainee @TheEBMT
0
2
6
Welcome to Day 3ļøā£ of #CART26 ā”ļø Browse the scientific programme to view all today's sessions. We encourage you to stay until the end for the Closing, Abstract Awards, and to find out when and where #CART27 will take place! š° https://t.co/s31w9kB84v
0
4
9
It was fantastic to catch up with @H_Einsele at #CART26 just now to hear about all things CAR-T in #myeloma ā from dual-antigen-targeting approaches to the potential of redefining second-line therapy with CAR-T.𩸠Full interview coming soon! š https://t.co/O9p0vDBrzw
#ImmunoOnc
0
1
8
#CART26 | Earlier today, we spoke with @nilalbiol of @hospitalclinic, who discussed the results of the multicenter retrospective study investigating the safety & efficacy of var-cel (ARI-0001) in R/R mantle cell #lymphoma. We'll be sharing the interview with you soon!š„ #LYMsm
0
2
2
Improves in AE management, but.. still risk factors are neccessary to indentify: 1) CRS 2) cardiac & lung 3) age doesnāt matter, but ECOG YES 4) In autoinmune diseases, AEs are different.. with ots OWN āFLAREā effect in damaged organs!! (LICATS) #CART26 @TheEBMT @EHA_Hematology
3
4
12
Privileged to present Phase 2 results #NexCAR19 r/r B-ALL at Best Abstracts Session #Cart26 @EHA_Hematology @TheEBMT We report 100% ORR/85% CR @ P2D & low toxicity Pre-infusion blasts>5% predictive of PR/early relapse @purwarrahul2 @ActImmuno @CTCTC_tmc @ACTREC_TMC @TataMemorial
2
11
26
It was a true pleasureāthanks to the financial support of @theEBMT, to share our exciting latest results on CAR T-cell therapy in multiple myeloma. I hope to have convinced you how AI can advance molecular medicine. #cart26 #staytuned
0
1
8
The #CART26 Virtual Platform will remain open until 23 March to enjoy all the meeting content on demand. š» Virtual registration is still open to catch up on the latest news in the field. ā”ļø https://t.co/HEM11M9srn
0
3
7
Amazing data #CART26 for #Myeloma! 1/3 #Ciltacel patients achieve 5y MRD- remission = CURED!!! @EHA_Hematology @young_eha @TheEBMT_Trainee @TheEBMT
0
6
11
#CART26 āIf patient is not responding⦠itās progressing ā CAR-T cells in #Myeloma The sooner the better!!! @TheEBMT_Trainee @TheEBMT @EHA_Hematology @young_eha
0
3
6
New CAR-T products emerging⦠now its time for Eque-cel! šš½š„ #CART26 @TheEBMT @EHA_Hematology
0
2
8